Plays Big Boards & Biotechs! Boardmark me as I am an honest, transparent, & well respected investor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx Kei! You have been making some solid trades as well. Keep it up!
New Economy Portfolio Update..Alert..exited remainder 2% position of $MRNS this morning at $1.36. It got to $1.53 in the AH yesterday. This morning opened much lower.
Disclaimer:..http://bit.ly/OlN9DB
J.P. Morgan..Research Articles in Biotech & Pharma.
2017 US Pharma Review
http://jpmorgan.metameetings.com/confbook/healthcare17/stash/misc/121316%202017%20US%20Pharma%20Preview.pdf
2017 US Biotech Outlook
http://jpmorgan.metameetings.com/confbook/healthcare17/stash/misc/JPM_2017_US_Biotech_Outlook_2016-12-13_2206029.pdf
JP Morgan US Biotech Research
http://jpmorgan.metameetings.com/confbook/healthcare17/stash/misc/2017%20JPM%20Conference%20Playbook%20-%20Final.pdf
Baird's Top #Biotech Picks for 2017.. $VRTX $SRPT $CRIS $BMRN $PRTK
http://bit.ly/Baird2017TopPicks
John Paulson Continues to Buy These 8 Stocks.. #Biotech $ARDM $LOXO $BIIB
http://finance.yahoo.com/news/john-paulson-continues-buy-8-205301457.html
New Economy Portfolio Update..alert..exited a position today! 2.9m shares traded today.
Alert.Exited $MRNS at $1.37 w/ 8% position from entry yesterday at $1.04 for a 30% gain. Kept about 2% in case it moves again tomorrow.
Disclaimer:..http://bit.ly/OlN9DB
$MRNS..$1.29 This one is moving well today into the close on 2.1m shares. Definitely a 25% move here. Much faster than I thought.
$ARQL..$1.50..moving on some good volume here of 220K shares.
$NTRPD..$7.47..Trading here at pre-split of close to $.25/$.26 now.
$NTRP..doing a 1:32 R/S. Uplisting to Nasdaq. Alzheimer's data in April finance… $NTRPD
http://finance.yahoo.com/news/neurotrope-announces-reverse-split-common-133000923.html?soc_src=social-sh&soc_trk=tw
$NTRP is uplisting to the Nasdaq! the share structure they had in place was not good
and wouldn't allow the big boys to play. 257m o/s was too high.
Instituitions and funds that can't buy OTC will now be able to buy the stock which is good.
A lot better coverage for the company.
The shares aren't trading on TD Ameritrade yet but they will.
$SGYP..$6.62..I expect approval from their PDUFA date in January. Orbimed expects the company to get bought out in the first half of 2017.
$ARQL..$1.40..Looks like mid to late March for data release. Looks like a solid catalyst play you brought to the thread
ARQL P3 data date (03/31/17): http://biopharmcatalyst.com/calendars/fda-calendar
Beginner Portfolio Update..bought shares of a position that has key data.
$ARQL..$1.40..bought 20% position in this stock. Key catalyst data in March.
Disclaimer: http://bit.ly/OlN9DB
$ARQL
Tivantinib: http://files.shareholder.com/downloads/ARQL/3597468867x0x916013/3E30ECE0-36F9-4229-BEC1-6ED16F3DDED4/Tivantinib_-_November_2016.pdf
Nov 2017 Corp Presentation
http://files.shareholder.com/downloads/ARQL/3597468867x0x916021/B82FBC83-CF87-4DB7-8D81-4BE32C63CFD0/Corporate_Deck_-_November_2016.pdf
Sept 28, 2016
http://wsw.com/webcast/leerink27/arql/index.aspx
$CEMP..$3.30..not on my radar here after getting CRL on two PDUFA dates 12/27 & 12/28. Could be a bouncer but they have a long road to go.
New Economy Portfolio Update..bought several positions today!
Alert.$MRNS at $1.05 a 8% position. Will do more DD later today. Company is trading at cash here!
Alert..bought $SGYP at $6.63 today 10% position
Alert..bought $LXRX at $13.67 today 10% position
Disclaimer:..http://bit.ly/OlN9DB
Agree with you there bigcat2. Not one I like to spend a lot of time with on this thread. Too many other big board biotech/pharma companies to play.
------------------------------------------------------------------
ELTP - I know your post was not directed at me :)
IMO - ELTP threw away any investor trust it had remaining on the last CRL. They still haven't explained or said what the CRL was or how long it will take to fix.
12 million in cash as of 3 months ago. Market cap 150 million with 10 million in revenue last year.
I'm still confused what's going on and wouldn't buy until I knew a date at the very least.
$ELTP..$.165 Will require some time obviously and hard to know the path until notes are released. They had an opportunity in 2016 but the CRL really set them back. They need to do an R/S as their share structure is entirely too big and they have little cash.
Opportunity to buy here! ..Haven't bought all week w/ the #JPM17 conf euphoria but now it's time to hone in on some bargains! $IBB $XBI
$ETRM..$18..a high today which is double the $9 last week.
Great move today! $ARIA..$24/share
$ETRM..$9.19 from $1.60 on Monday.Yes I see it was mentioned on 8/23/16 but the stock was crap at that time so its not relevant to now! People are talking about it now because of its amazing week but that is the only reason why. It has emerged this week due to news and the fact the stock did an R/S and they retired lots of debt. That set it up for a classic short squeeze.
$DCTH..$.52..getting crushed down 36%. Look at the link to their financial position. This was toxic from the beginning! Once the company cleans this up, they will be more attractive to retail investors & institutions.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127529527&txt2find=dcth
Beginner Portfolio Update...Bought a lotto position in a new stock for my board. This is the DD Post Link.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127654912
Alert..bought $PIOI at $.20 & $.21 in my Beginner Portfolio. Bought a 15% position (50K shares at $.205 ) in the stock. Only sharing the share position because it is a lotto play in my Beginner Portfolio & I want folks to know how many shares I am playing with here. I typically never post the share count but % of shares relative to Dollar amount.
Disclaimer: http://bit.ly/OlN9DB
$MYOK..$14.10..files 250M shelf.
Attn: Rare Lotto Play on the thread..I typically rarely if ever do lotto plays (OTC non-bio) on the board but I like one that I have been researching for the past few weeks. I typically allow two to three per year if that. They have always been biotech stocks but this is the first non-biotech stock I have allowed & it is awaiting news here shortly. ASH has been doing a lot of DD on the stock. The ticker is $PIOI. That is a LOTTO play on the thread!
DD from ASH111..PIOI Full DD, 01/04/17 : Mid-Long Term holding, main reasons:
PIOI in the process of undertaking the activities and negotiations with investors. it could be done overnight but also in Q1 2017,like any complex transaction.
1) Debt free.
2) 500m+ NOLs
3) >20 patents to monetize
4) $4,1mm tax credit
5) at least $1mm cash
6) insiders ownership 40%
7) some institutionals increased their positions
8) new investors will bring cash
9) ready to acquire profitable businesses
10) insiders accepted to be paid with shares at 1,30$ per share (half 2015 compensation)
Based On RELY's same deal the value is at least $100m. RELY trading almost 40 times PIOI, w/only 80% higher value in NOls :
It's important to note that RELY's acquisition has yet to result in profitable operations which is why their market cap isn't even higher than the current $177.6m. Although it will be difficult for those of us that are already in to hold beyond $1.00/$1.30, a decent patent evaluation and viable acquisition could put this well above that.( No-dough-go comments).
PIOI a $4M cap co. A/o today( w/zero debt) W/$500m+ NOLs,
https://finance.yahoo.com/news/active-power-adopts-tax-benefit-000026095.html
RELY a $200M Company W/ $900M+ NOLs
http://seekingalpha.com/article/3958586-real-industry-200m-company-900m-nols
In addition, PIOI has 20 registered Patents: on a conservative estimation of only $1m per patent we have an additional value of more $20m. http://www.p10industries.com/patent-licensing
I think we might see a private placement at around $1.3. shareholders accepted to be paid with shares at $1.3 and exactly those shareholders approved the deal.
"On September 21, 2016, we received a non-binding term sheet from a potential investor in Active Power regarding a proposal for Active Power to acquire an existing profitable operating company".
"On September 26, 2016, our board of directors held a special telephonic meeting. At the meeting, Mr. Ascolese updated our board of directors on the status of the negotiations with Langley and negotiations with three potential investors in Active Power".
slojab
Sunday, 11/20/16 07:19:03 PM
Re: None
Post # of 1550
I received two emails responses from Jay Powers.
On 11/20/2016 10:57 AM, Jay Powers wrote:
Thank you for your comment and support. As our press release indicated we continue in our efforts to raise additional capital to support the working capital and acquisition strategy of the business and we anticipate that this step will be completed before the end of the year. Our objective is to monetize the patents that we retained and to acquire well run and profitable businesses. We do anticipate that this will result in increased shareholder value.
Thank you
Jay Powers
CFO
After I responded to him, he replied again....
As you can see in our 2015 10K filing, our domestic Federal NOL’s at the time were $235.5M. There are stringent IRS regulations essentially prohibiting a company to acquire control of another entity and utilize the NOL’s. The NOL’s can be used by the entity generating the losses including the profits of entities it may acquire.
For clarification, no company will be acquiring the ACPW ticker. The asset purchase agreement with Piller required us to change our name because they will continue to use the Active Power brand. We are changing our name to P10 Industries and therefore required to change our ticker.
Thank you for your interest.
Jay Powers
Bustajoy
Tuesday, 01/03/17 12:48:03 PM
Re: EnricoMania post# 1749
Post # of 1770
Got an email from the president and CEO this time around. Sounds optimistic, and said they are well down the path of implementing the go-forward strategy, and as soon as they have something of substance, they will announce.
"We are looking forward to successfully implementing the strategy, and as you can imagine these transactions take longer than one would expect, and like you I find it hard to be patient in the mean time...".
Looks like they are just trying to put the last pieces together. Hopefully something soon enough. Sounded optimistic and about ready to pop out the pr, just making sure everything is right.
About NOLs:
(EnricoMania Comments):
look here to see how NOLs are used by companies to offset taxes.
https://globenewswire.com/news-release/2016/12/28/901923/0/en/Live-Ventures-Announces-Biggest-Year-in-Company-History-Achieving-Record-Earnings-of-8-92-Per-Share-With-Continued-Growth-Anticipated-in-2017.html
"The company’s outstanding year-end results were partially attributable to the stellar performance at its wholly owned subsidiary, Marquis Industries, and partially to other non-cash income realized in connection with the Company’s deferred tax assets. These net operating losses (NOLs) were accumulated prior to Live Ventures becoming a diversified holding company and allow it to defer over $30M in future income. The NOLs provide the company a unique advantage in that it can keep a substantial portion of its income -- which normally would have been expensed at approximately 35 percent for taxes, and redeploy it in other areas such as stock repurchases, retirement of debt, or new acquisitions. Although a portion of this year’s earnings was attributable to its deferred tax assets, management believes the growth factors explained below will offset non-cash income realized during this year".
$ZSAN..Last Patient Treated in its Migraine Pivotal Trial. Top line data 1Q 2017.
http://finance.yahoo.com/news/zosano-pharma-announces-last-subject-133000661.html?soc_src=social-sh&soc_trk=tw
Excellent Mark! Well done.
Its 5m upfront immediately. The other payments are contingent on other royalties, etc. $CBAY
$SGYP..$6.80..PDUFA is upcoming in Jan. I think its important for investors to take advantage of these moves in the stock prior to their PDUFA. Company still has a bloated share structure and not a lot of cash. I still like how the company has moved higher though.
Thx BioHunter! Having you on the thread has been a great addition here. Appreciate your informative DD posts & keen insight into the biotech market as well as DD behind why you may or may not own a stock. Thanks again for 2016! 2017 should be a better biotech year overall.
$AGRX..Exactly! That is getting crushed here down 77% to $1.30 here. Wow.
$ADHD..Good info ASH. The update regarding the meeting they had with the FDA should be soon. They sent out a PR on Dec 14th and mentioned they would update in the "coming weeks."
New Economy Portfolio 2016 YE Update: 2016 was a great year!
Mid Year July 2016 Review Here: http://bit.ly/2hKPVsE
Began 2016 w/ $417k. Had $495 thru June 2016
Oct 2016 Update Here: http://bit.ly/2j1u9B1
Thru Sept 2016 had $601k 45% gain.
Ended 2016 w/ $568K for a 35% gain. Gave back 33K in gains in 4Q16. Last year (2015) I was up 15% on the year so more than doubled my return this year. I started with 60K in 2011/2012 so % year over year has been strong the past four yrs!
Goal at YE was 600k so fell short by 30K. (link back..http://bit.ly/2daI1EI) Continued base hits, singles, one HR was $CPXX. Tried to focus Q4 on being smart with trades for year without giving back most of my gains for 2016 even though I did give back some. This is one of my most active trading portfolio that I have shared the past 5 yrs. My other portfolios have longer-term holdings and aren't as actively traded.
Goals for 2017 is a 50% gain which is or $855,000. Going to invest in cash rich undervalued biotechs that have catalysts but have been languishing. They will take more patience but my hope is that risk will be lower & rewards higher. Will still hold a few binary plays up to data but very few through data.
Continued success to all. Look forward to 2017! Sheff
Finished in the Top 10. Thx everyone for voting! There are some good traders out there that do more than just biotech. Hopefully next year I get put on the original
Ballet and I am not a last-minute fill in:)